Since its launch in Japan in 2020, Ubie’s AI Symptom Checker has racked up more than a hundred million uses in total, a testament to its truly extensive effect in bringing patients and healthcare closer together. Following its good fortune in Japan, the U. S. version, released in 2022, has surpassed 2 million uses (press release), making it even less difficult for healthcare providers to connect with those who need medical advice. Kota Kubo, CEO of Ubie, Inc. , says, “We are in a position to continue this expansion trajectory and are excited to announce plans for the upcoming launch of our Android app in the U. S. market. “We are not going to be able to do anything Ubie, Inc. remains committed to expanding and improving its services, striving to exceed customer expectations and contribute to improving the overall accessibility of healthcare.
About Google Play Best of 2023
Ubie was proudly identified as a winner in the “Best with AI” category. This prestigious award reflects Ubie’s commitment to integrating synthetic intelligence in a way that truly complements the user experience and meets real-world needs.
For an in-depth look at Google Play Best of 2023 and see the list of winners, visit the official website: https://play. google. com/best-of-2023
*Google Play is a registered trademark of Google LLC.
About Ubie’s AI Symptom Checker:
Ubie’s AI symptom checker makes it simple for users to search for healthcare data and locate suitable healthcare providers. Available in Japanese and English, it helps users identify symptoms and connect with appropriate healthcare providers.
About Ubie, Inc. :
Ubie, Inc., established in 2017, is at the forefront of the digital health revolution. As an innovative startup, Ubie harnesses the power of artificial intelligence to seamlessly navigate individuals towards appropriate healthcare services. Our mission is rooted in the belief that everyone, regardless of location or circumstance, deserves access to comprehensive healthcare. We are committed to transforming this vision into reality by creating a more accessible and user-friendly healthcare experience.
Our global presence is anchored by our headquarters in Tokyo, Japan, located in downtown Nihonbashi-Horidomecho, and our US headquarters in bustling downtown New York City. These strategic locations allow us to domesticate and expand our impact on healthcare. industry around the world.
Japan Headquarters: Floor, Nihonbashi-Horidomecho 2-chome Bldg. 2-4-3, Horidomecho, Nihonbashi, Chuo-ku, Tokyo, 103-0012
Created: May 2017 – Japan Operations October 2022 – United States Operations
Leadership:
Co-founders, Kota Kubo and Dr. Yoshinori Abe, spearhead our ambitious adventure with a shared commitment to healthcare accessibility through cutting-edge solutions.
Disclaimer: Please note that the Ubie AI Symptom Checker is intended for informational purposes only and is not a substitute for professional medical diagnosis, recommendation, or remedy plan. Users deserve to seek the recommendation of qualified medical professionals in relation to any medical condition or remedy decision.
Contact: Ryosei Hatakeyama Ubie, Inc. 1460 Broadway, New York, NY 10036 Email: pr@ubiehealth. com
View content to download multimedia: https://www. prnewswire. com/news-releases/ubie-won-the-best-with-ai-in-google-play-best-of-2023-japan-302013922. html
SOURCE Ubie, Inc.